Literature DB >> 19203742

Genetic and non-genetic determinants of outcomes in cystic fibrosis.

Linda L Wolfenden1, Michael S Schechter.   

Abstract

The treatment of cystic fibrosis has improved significantly over the past three decades. Median survival has improved by decades and is now estimated to be 37 years. Many factors contribute to improvements in disease severity and outcome. This paper reviews the current evidence of three groups of important factors: genetic, environmental and healthcare related.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19203742     DOI： 10.1016/j.prrv.2008.04.002

Source DB:  PubMed          Journal:  Paediatr Respir Rev        ISSN： 1526-0542            Impact factor:   2.726


  10 in total

Review 1.  Cystic fibrosis: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases.

Authors:  Jessica E Pittman; Garry Cutting; Stephanie D Davis; Thomas Ferkol; Richard Boucher
Journal:  Ann Am Thorac Soc       Date:  2014-04

2.  Effects of gender and age at diagnosis on disease progression in long-term survivors of cystic fibrosis.

Authors:  Jerry A Nick; Cathy S Chacon; Sara J Brayshaw; Marion C Jones; Christine M Barboa; Connie G St Clair; Robert L Young; David P Nichols; Jennifer S Janssen; Gwen A Huitt; Michael D Iseman; Charles L Daley; Jennifer L Taylor-Cousar; Frank J Accurso; Milene T Saavedra; Marci K Sontag
Journal:  Am J Respir Crit Care Med       Date:  2010-05-06       Impact factor: 21.405

3.  An activated immune and inflammatory response targets the pancreas of newborn pigs with cystic fibrosis.

Authors:  Maisam Abu-El-Haija; Marek Sinkora; David K Meyerholz; Michael J Welsh; Paul B McCray; John Butler; Aliye Uc
Journal:  Pancreatology       Date:  2011-11-01       Impact factor: 3.996

4.  Hoping to live a "normal" life whilst living with unpredictable health and fear of death: impact of cystic fibrosis on young adults.

Authors:  Lorraine Higham; Shenaz Ahmed; Mushtaq Ahmed
Journal:  J Genet Couns       Date:  2012-12-14       Impact factor: 2.537

Review 5.  Socioeconomic determinants of respiratory health in patients with cystic fibrosis: implications for treatment strategies.

Authors:  Gabriela R Oates; Michael S Schechter
Journal:  Expert Rev Respir Med       Date:  2022-06-23       Impact factor: 4.300

Review 6.  The Evolution of Cystic Fibrosis Care.

Authors:  Jessica E Pittman; Thomas W Ferkol
Journal:  Chest       Date:  2015-08       Impact factor: 9.410

7.  Tobacco smoke exposure and socioeconomic factors are independent predictors of pulmonary decline in pediatric cystic fibrosis.

Authors:  Gabriela R Oates; Elizabeth Baker; Steven M Rowe; Hector H Gutierrez; Michael S Schechter; Wayne Morgan; William T Harris
Journal:  J Cyst Fibros       Date:  2020-02-17       Impact factor: 5.482

8.  Genes that determine immunology and inflammation modify the basic defect of impaired ion conductance in cystic fibrosis epithelia.

Authors:  Frauke Stanke; Tim Becker; Vinod Kumar; Silke Hedtfeld; Christian Becker; Harry Cuppens; Stephanie Tamm; Jennifer Yarden; Ulrike Laabs; Benny Siebert; Luis Fernandez; Milan Macek; Dragica Radojkovic; Manfred Ballmann; Joachim Greipel; Jean-Jacques Cassiman; Thomas F Wienker; Burkhard Tümmler
Journal:  J Med Genet       Date:  2010-09-12       Impact factor: 6.318

9.  Early childhood lung function is a stronger predictor of adolescent lung function in cystic fibrosis than early Pseudomonas aeruginosa infection.

Authors:  Jessica E Pittman; Hannah Noah; Hollin E Calloway; Stephanie D Davis; Margaret W Leigh; Mitchell Drumm; Scott D Sagel; Frank J Accurso; Michael R Knowles; Marci K Sontag
Journal:  PLoS One       Date:  2017-05-15       Impact factor: 3.240

10.  Rescue therapy within the UK Cystic Fibrosis Registry: An exploration of predictors of intravenous antibiotic use amongst adults with CF.

Authors:  Zhe Hui Hoo; Martin J Wildman; Rachael Curley; Stephen J Walters; Michael J Campbell
Journal:  Respirology       Date:  2017-09-14       Impact factor: 6.424
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.